China Universal Asset Management Co., Ltd. Fusion Pharmaceuticals Inc. Transaction History

China Universal Asset Management Co., Ltd.

  • $893 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024
BUY
$7.9 - $21.32 $43,797 - $118,198
5,544 Added 66.19%
13,920 $297,000
Q4 2023

May 21, 2024
SELL
$2.48 - $9.65 $13,749 - $53,499
-5,544 Reduced 39.83%
8,376 $80,000
Q4 2023

Jan 23, 2024
BUY
$2.48 - $9.65 $20,772 - $80,828
8,376 New
8,376 $80,000

Others Institutions Holding FUSN

# of Institutions
5
Shares Held
93K
Call Options Held
1.4K
Put Options Held
0
View Full List

About Fusion Pharmaceuticals Inc.

FUSN Quotes by TradingView
  • Ticker FUSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,390,500
  • Description
  • Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...
More about FUSN
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email